Evidence map›Paper›PMID 38252873›Full record

ArticleThe Journal of clinical endocrinology and metabolism2024

Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.

Vincenzo Condello, Anello M Poma, Elisabetta Macerola, Paola Vignali, Johan O Paulsson, Jan Zedenius, Fulvio Basolo, C Christofer Juhlin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Vincenzo CondelloDepartment of Oncology-Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.ORCID 0000-0003-4569-5398
Anello M PomaDepartment of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-0212-8249
Elisabetta MacerolaDepartment of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-0235-799X
Paola VignaliDepartment of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.
Johan O PaulssonDepartment of Oncology-Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.ORCID 0000-0003-0390-6740
Jan ZedeniusDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 64 Stockholm, Sweden.ORCID 0000-0003-2833-3758
Fulvio BasoloDepartment of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-1657-5020
C Christofer JuhlinDepartment of Oncology-Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.ORCID 0000-0002-5945-9081
University of Pisa · ITKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

The Swedish Cancer Society CAN 2020/426Wellcome Trust 224053
6 · The paper itself

Abstract

backgroundMutations in micro-RNA (miRNA) regulators DICER1 and DGCR8 have recently been uncovered, revealing a potential novel mechanism driving thyroid tumor development. However, the true frequency of these hotspot mutations in follicular-patterned thyroid tumors (FTs) and their relation to established driver gene events remain elusive.

methodsA total of 440 FTs from 2 institutions were interrogated for DICER1, DGCR8, and RAS family hotspot mutations using Sanger sequencing. Whole-exome sequencing was also performed to identify additional driver gene aberrations in DICER1/DGCR8-mutant cases. Subsets of cases were further analyzed using miRNA expression profiling, and key dysregulated miRNAs were validated as markers of DICER1 mutations using quantitative RT-PCR analysis. The Cancer Genome Atlas (TCGA) database was also probed for DICER1/DGCR8 mutations and miRNA dysregulation.

resultsFourteen (3.2%) and 4 (1%) FTs harbored DICER1 and DGCR8 hotspot mutations, respectively, in the combined cohort, and no cases with normal tissue available were found to exhibit a constitutional variant. Two DGCR8-mutant cases also harbored oncogenic RAS mutations. Whole-exome sequencing analysis did not identify additional driver gene events in DICER1/DGCR8-positive cases. Comprehensive miRNA expression profiling revealed a unique pattern of dysregulated miRNAs in DICER1/DGCR8-mutant cases compared with wild-type lesions. Moreover, DICER1-mutant cases showed a remarkable reduction of 5' arm miRNAs, findings corroborated in the TCGA cohort.

conclusionDICER1 and DGCR8 hotspot mutations are rare in unselected cohorts of FTs, and mutated cases exhibit a specific miRNA profile. Although DGCR8 mutations may coexist with established RAS gene alterations, FTs with DICER1 variants were devoid of other driver gene events.

Indexed as

DEAD-box RNA HelicasesMicroRNAsMutationRibonuclease IIIRNA-Binding ProteinsThyroid NoduleAdenocarcinoma, FollicularAdultAgedExome SequencingFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrevalenceDEAD-box RNA HelicasesDGCR8 protein, humanDICER1 protein, humanMicroRNAsRibonuclease IIIRNA-Binding ProteinsDGCR8DICER1miRNAthyroid nodules

Identifiers

PMID38252873
PMCPMC11180504
OpenAlexW4391091830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.